Role of Pancreatic Juice Cytology in the Preoperative Management of Intraductal Papillary Mucinous Neoplasm of the Pancreas in the Era of International Consensus Guidelines 2012

[1] Tanaka M(2006)International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas Pancreatology 6 17-32

[2] Chari ST(2012)International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas Pancreatology 12 183-197

[3] Adsay V(2009)Intraductal papillary mucinous neoplasms of the pancreas: differentiation of malignant and benign tumors by endoscopic ultrasonography findings of mural nodules Ann Surg 249 628-634

[4] Tanaka M(2012)An increase in the number of predictive factors augments the likelihood of malignancy in branch duct intraductal papillary mucinous neoplasm of the pancreas Surgery 151 76-83

[5] Fernández-del Castillo C(2013)Predictors of malignancy in intraductal papillary mucinous neoplasm of the pancreas: analysis of 310 pancreatic resection patients at multiple high-volume centers Pancreas 42 883-888

[6] Adsay V(2010)Histopathologic basis for the favorable survival after resection of intraductal papillary mucinous neoplasm-associated invasive adenocarcinoma of the pancreas Ann Surg 251 470-476

[7] Ohno E(2011)Prognostic relevance of morphological types of intraductal papillary mucinous neoplasms of the pancreas Gut 60 509-516

[8] Hirooka Y(2011)Prognosis of invasive intraductal papillary mucinous neoplasm depends on histological and precursor epithelial subtypes Gut 60 1712-1720

[9] Itoh A(2007)Branch-duct intraductal papillary mucinous neoplasms: observations in 145 patients who underwent resection Gastroenterology 133 72-79

[10] Ohtsuka T(2011)Natural history of branch duct intraductal papillary mucinous neoplasms of the pancreas: a multicenter study in Japan Pancreas 40 364-370

[1] Tanaka M(2006)International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas Pancreatology 6 17-32

[2] Chari ST(2012)International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas Pancreatology 12 183-197

[3] Adsay V(2009)Intraductal papillary mucinous neoplasms of the pancreas: differentiation of malignant and benign tumors by endoscopic ultrasonography findings of mural nodules Ann Surg 249 628-634

[4] Tanaka M(2012)An increase in the number of predictive factors augments the likelihood of malignancy in branch duct intraductal papillary mucinous neoplasm of the pancreas Surgery 151 76-83

[5] Fernández-del Castillo C(2013)Predictors of malignancy in intraductal papillary mucinous neoplasm of the pancreas: analysis of 310 pancreatic resection patients at multiple high-volume centers Pancreas 42 883-888

[6] Adsay V(2010)Histopathologic basis for the favorable survival after resection of intraductal papillary mucinous neoplasm-associated invasive adenocarcinoma of the pancreas Ann Surg 251 470-476

[7] Ohno E(2011)Prognostic relevance of morphological types of intraductal papillary mucinous neoplasms of the pancreas Gut 60 509-516

[8] Hirooka Y(2011)Prognosis of invasive intraductal papillary mucinous neoplasm depends on histological and precursor epithelial subtypes Gut 60 1712-1720

[9] Itoh A(2007)Branch-duct intraductal papillary mucinous neoplasms: observations in 145 patients who underwent resection Gastroenterology 133 72-79

[10] Ohtsuka T(2011)Natural history of branch duct intraductal papillary mucinous neoplasms of the pancreas: a multicenter study in Japan Pancreas 40 364-370